Intrinsic Value of S&P & Nasdaq Contact Us

111, Inc. YI NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • CN • USD

SharesGrow Score
29/100
1/5 Pass
SharesGrow Intrinsic Value
$32.89
+383%

111, Inc. (YI) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysts estimate Earnings Per Share (EPS) of $3.57 and revenue of $2.12B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-7.52 vs est $3.57 (missed -310.8%). Analyst accuracy: 0%.

EPS Estimates — YI

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$7.52 vs Est $3.57 ▼ 147.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

Revenue Estimates — YI

15%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $14.401B vs Est $2.122B ▲ 85.3% off
Revenue Trend
Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message